TY  - GEN
AU  - Kang,Yu Mi
AU  - Jung,Chang Hee
AU  - Lee,Seung Hwan
AU  - Kim,Sang Wook
AU  - Song,Kee Ho
AU  - Kim,Sin Gon
AU  - Kim,Jae Hyeon
AU  - Cho,Young Min
AU  - Park,Tae Sun
AU  - Ku,Bon Jeong
AU  - Koh,Gwanpyo
AU  - Kim,Dol Mi
AU  - Lee,Byung Wan
AU  - Park,Joong Yeol
TI  - Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
SN  - 2233-6079
PY  - 2020///0527
KW  - Aged
KW  - Blood Glucose
KW  - analysis
KW  - Body Weight
KW  - drug effects
KW  - Diabetes Mellitus, Type 2
KW  - drug therapy
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - adverse effects
KW  - Drug Therapy, Combination
KW  - Female
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemia
KW  - chemically induced
KW  - Hypoglycemic Agents
KW  - Insulin Glargine
KW  - Male
KW  - Metformin
KW  - Middle Aged
KW  - Sulfonylurea Compounds
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.4093/dmj.2018.0092
ER  -